Food and Drug Administration (FDA) for managing type 2 diabetes under the brand names Ozempic (injection) and Rybelsus (tablet), and for chronic weight management as Wegovy , this medication continues to make a major impact in both clinical and wellness settings
Treatment decisions should be made collaboratively, weighing the benefits of continued weight management against the impact of side effects
The medication works best when combined with a reduced-calorie diet and exercise program
4C,D), whereas semaglutide considerably reduced energy expenditure and RER (Fig
And a GLP-1 named Wegovy secured a supplemental cardiovascular indication from the Food and Drug Administration this spring
While GLP-1 refers to the broader class of medications, semaglutide is a specific drug within this category, available under brand names like Wegovy and Ozempic